Maxim Doubles Price Target on Athersys (ATHX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Wall St to open higher on oil retreat, tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
Athersys (ATHX) Pops Higher on Strong MultiStem Data in Treating MS
October 5, 2012 9:48 AM EDTAthersys, Inc. (Nasdaq: ATHX) shares are up early on the session Friday after issuing the following release. Athersys reported significant data for MultiStem cells on treating MS.
The full release is below:
[Athersys, Inc.] announced today it is presenting new research results at the Second Midwest Conference on Stem Cell Biology & Therapy at Oakland University in... More
